108 related articles for article (PubMed ID: 34232007)
1. [Breast cancer, the risk attributable to type 2 diabetes].
Ruiz-Betancourt BS; González-León M; Nájera N; Ceballos G; Ovalle O; López-Reyna JCB; Nuñez-Torrez EC
Rev Med Inst Mex Seguro Soc; 2021 Jun; 59(2):141-150. PubMed ID: 34232007
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in Mexican women: an epidemiological study with cervical cancer control.
Tovar-Guzmán V; Hernández-Girón C; Lazcano-Ponce E; Romieu I; Hernández Avila M
Rev Saude Publica; 2000 Apr; 34(2):113-9. PubMed ID: 10881145
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
Maskarinec G; Shvetsov YB; Conroy SM; Haiman CA; Setiawan VW; Le Marchand L
Breast Cancer Res Treat; 2019 Feb; 173(3):637-645. PubMed ID: 30367331
[TBL] [Abstract][Full Text] [Related]
4. Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study.
de Los A Jiménez Prieto P; Alvarez Bañuelos MT; Romero JM; Córdoba BC; Sampieri CL; Cuevas RZ; Guzmán García RE
J Diabetes Complications; 2022 Aug; 36(8):108249. PubMed ID: 35803840
[TBL] [Abstract][Full Text] [Related]
5. [INFLUENCE OF REPRODUCTIVE FACTORS, BREASTFEEDING AND OBESITY ON THE RISK OF BREAST CANCER IN MEXICAN WOMEN].
Navarro-Ibarra MJ; Caire-Juvera G; Ortega-Vélez MI; Bolaños-Villar AV; Saucedo-Tamayo Mdel S
Nutr Hosp; 2015 Jul; 32(1):291-8. PubMed ID: 26262729
[TBL] [Abstract][Full Text] [Related]
6. Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women.
Hayes J; Richardson A; Frampton C
Intern Med J; 2013 Nov; 43(11):1198-204. PubMed ID: 23910051
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy and risk of breast cancer in mexican women.
Amadou A; Fabre A; Torres-Mejía G; Ortega-Olvera C; Angeles-Llerenas A; McKenzie F; Biessy C; Hainaut P; Romieu I
PLoS One; 2013; 8(11):e79695. PubMed ID: 24260282
[TBL] [Abstract][Full Text] [Related]
8. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
Ratanawichitrasin A; Reansuwan W; Ratanawichitrasin S; Bhodhisuwan K; Kongpatanakul S
J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
[TBL] [Abstract][Full Text] [Related]
9. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women.
Bao PP; Zhao ZG; Gao YT; Zheng Y; Zhang B; Cai H; Zheng W; Shu XO; Lu W
PLoS One; 2015; 10(2):e0117419. PubMed ID: 25679392
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk factors in Turkey: a hospital-based case-control study.
Sezer H; Yilmaz M; Gurler H; Koyuncu A
Asian Pac J Cancer Prev; 2011; 12(9):2317-22. PubMed ID: 22296377
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay.
Ronco AL; De Stefani E; Deneo-Pellegrini H; Quarneti A
Asian Pac J Cancer Prev; 2012; 13(1):139-46. PubMed ID: 22502657
[TBL] [Abstract][Full Text] [Related]
12. Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort.
Al Ajmi K; Lophatananon A; Mekli K; Ollier W; Muir KR
JAMA Netw Open; 2020 Apr; 3(4):e203760. PubMed ID: 32329772
[TBL] [Abstract][Full Text] [Related]
13. Nutritional factors and breast cancer in Mexico.
Bonilla-Fernández P; López-Cervantes M; Torres-Sánchez LE; Tortolero-Luna G; López-Carrillo L
Nutr Cancer; 2003; 45(2):148-55. PubMed ID: 12881007
[TBL] [Abstract][Full Text] [Related]
14. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
15. Sex/Gender Modifies the Association Between the MC4R p.Ile269Asn Mutation and Type 2 Diabetes in the Mexican Population.
Vázquez-Moreno M; Locia-Morales D; Valladares-Salgado A; Sharma T; Wacher-Rodarte N; Cruz M; Meyre D
J Clin Endocrinol Metab; 2021 Jan; 106(1):e112-e117. PubMed ID: 33045043
[TBL] [Abstract][Full Text] [Related]
16. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study.
Sellers TA; Jensen LE; Vierkant RA; Fredericksen ZS; Brandt KR; Giuliano AR; Pankratz VS; Cerhan JR; Vachon CM
Cancer Causes Control; 2007 Jun; 18(5):505-15. PubMed ID: 17437179
[TBL] [Abstract][Full Text] [Related]
17. Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case-control study in the EPIC Florence cohort.
Masala G; Ambrogetti D; Assedi M; Bendinelli B; Caini S; Palli D
Breast Cancer Res Treat; 2017 Jul; 164(2):467-473. PubMed ID: 28478611
[TBL] [Abstract][Full Text] [Related]
18. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
19. Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study.
Masala G; Bendinelli B; Assedi M; Occhini D; Zanna I; Sieri S; Agnoli C; Sacerdote C; Ricceri F; Mattiello A; Panico S; Tumino R; Frasca G; Saieva C; Palli D
Breast Cancer Res Treat; 2017 Jan; 161(2):311-320. PubMed ID: 27832394
[TBL] [Abstract][Full Text] [Related]
20. Prediabetes, diabetes, and risk of breast cancer: a case-control study.
Salinas-Martínez AM; Flores-Cortés LI; Cardona-Chavarría JM; Hernández-Gutiérrez B; Abundis A; Vázquez-Lara J; González-Guajardo EE
Arch Med Res; 2014 Jul; 45(5):432-8. PubMed ID: 24937172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]